logo of the EU drugs agency

You are viewing archived content

Please note that this page is a static copy of a previously published web page and is no longer actively maintained.
Be aware that the information contained here may be out-of-date.
For the most recent information, we recommend visiting the main website of the EMCDDA.

Figure HSR-1. Year of introduction of methadone maintenance and high dosage buprenorphine treatmentin 26 EU countries and Norway


Methadone maintenance treatment is not available in Cyprus.

Countries that did not report introduction of high dosage buprenorphine as treatment option are: Cyprus, Bulgaria, Hungary, Poland and Romania.


See detailed references in Table HSR-8.

See also 'General notes for interpreting data' on the Explanatory notes and help page.

Page last updated: Thursday, 15 November 2007